nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—lung cancer	0.409	1	CbGbCtD
Bimatoprost—PTGER3—mammary gland—lung cancer	0.0129	0.175	CbGeAlD
Bimatoprost—PTGER3—respiratory system—lung cancer	0.00858	0.116	CbGeAlD
Bimatoprost—PTGFR—respiratory system—lung cancer	0.00686	0.0931	CbGeAlD
Bimatoprost—PTGFR—bronchus—lung cancer	0.00565	0.0766	CbGeAlD
Bimatoprost—PTGFR—trachea—lung cancer	0.00507	0.0688	CbGeAlD
Bimatoprost—AKR1C3—bronchus—lung cancer	0.00459	0.0623	CbGeAlD
Bimatoprost—PTGER3—lung—lung cancer	0.00456	0.0619	CbGeAlD
Bimatoprost—AKR1C3—trachea—lung cancer	0.00412	0.0559	CbGeAlD
Bimatoprost—AKR1C3—cardiac atrium—lung cancer	0.00387	0.0525	CbGeAlD
Bimatoprost—PTGFR—lung—lung cancer	0.00364	0.0494	CbGeAlD
Bimatoprost—Dinoprost Tromethamine—HPGDS—lung cancer	0.00353	0.472	CrCbGaD
Bimatoprost—AKR1C3—Podofilox—Teniposide—lung cancer	0.00346	0.308	CbGdCrCtD
Bimatoprost—AKR1C3—bone marrow—lung cancer	0.00327	0.0444	CbGeAlD
Bimatoprost—PTGER3—lymph node—lung cancer	0.00312	0.0423	CbGeAlD
Bimatoprost—AKR1C3—lung—lung cancer	0.00296	0.0402	CbGeAlD
Bimatoprost—Dinoprostone—HPGDS—lung cancer	0.00271	0.363	CrCbGaD
Bimatoprost—PTGFR—lymph node—lung cancer	0.00249	0.0338	CbGeAlD
Bimatoprost—AKR1C3—Vincristine—Vinorelbine—lung cancer	0.00221	0.196	CbGdCrCtD
Bimatoprost—AKR1C3—Podofilox—Etoposide—lung cancer	0.00206	0.183	CbGdCrCtD
Bimatoprost—AKR1C3—lymph node—lung cancer	0.00202	0.0275	CbGeAlD
Bimatoprost—AKR1C3—Vinblastine—Vinorelbine—lung cancer	0.00177	0.157	CbGdCrCtD
Bimatoprost—AKR1C3—Vincristine—Vinblastine—lung cancer	0.00176	0.156	CbGdCrCtD
Bimatoprost—Tafluprost—PTGS2—lung cancer	0.00123	0.165	CrCbGaD
Bimatoprost—Nervous system disorder—Vinorelbine—lung cancer	0.000433	0.00144	CcSEcCtD
Bimatoprost—Cystitis noninfective—Doxorubicin—lung cancer	0.00043	0.00143	CcSEcCtD
Bimatoprost—Skin disorder—Vinorelbine—lung cancer	0.000429	0.00143	CcSEcCtD
Bimatoprost—Cystitis—Doxorubicin—lung cancer	0.000425	0.00142	CcSEcCtD
Bimatoprost—Mediastinal disorder—Cisplatin—lung cancer	0.00042	0.0014	CcSEcCtD
Bimatoprost—Rhinitis—Paclitaxel—lung cancer	0.000419	0.0014	CcSEcCtD
Bimatoprost—Pharyngitis—Paclitaxel—lung cancer	0.000415	0.00138	CcSEcCtD
Bimatoprost—Nausea—Teniposide—lung cancer	0.000414	0.00138	CcSEcCtD
Bimatoprost—Oedema peripheral—Paclitaxel—lung cancer	0.000412	0.00137	CcSEcCtD
Bimatoprost—Connective tissue disorder—Paclitaxel—lung cancer	0.000411	0.00137	CcSEcCtD
Bimatoprost—Dry eye—Doxorubicin—lung cancer	0.000407	0.00136	CcSEcCtD
Bimatoprost—Erythema—Cisplatin—lung cancer	0.000405	0.00135	CcSEcCtD
Bimatoprost—Visual impairment—Paclitaxel—lung cancer	0.000403	0.00134	CcSEcCtD
Bimatoprost—Vertigo—Irinotecan—lung cancer	0.000401	0.00134	CcSEcCtD
Bimatoprost—Eye disorder—Etoposide—lung cancer	0.000399	0.00133	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—lung cancer	0.000398	0.00133	CcSEcCtD
Bimatoprost—Dyspnoea—Vinorelbine—lung cancer	0.000394	0.00131	CcSEcCtD
Bimatoprost—Eye disorder—Paclitaxel—lung cancer	0.000391	0.0013	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—lung cancer	0.00039	0.0013	CcSEcCtD
Bimatoprost—Cough—Irinotecan—lung cancer	0.00039	0.0013	CcSEcCtD
Bimatoprost—Angiopathy—Etoposide—lung cancer	0.000387	0.00129	CcSEcCtD
Bimatoprost—Hypertension—Irinotecan—lung cancer	0.000385	0.00128	CcSEcCtD
Bimatoprost—Mediastinal disorder—Etoposide—lung cancer	0.000384	0.00128	CcSEcCtD
Bimatoprost—Vision blurred—Cisplatin—lung cancer	0.000382	0.00127	CcSEcCtD
Bimatoprost—Asthenia—Vinblastine—lung cancer	0.000381	0.00127	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000381	0.00127	CcSEcCtD
Bimatoprost—Cough—Gemcitabine—lung cancer	0.000379	0.00127	CcSEcCtD
Bimatoprost—Angiopathy—Paclitaxel—lung cancer	0.000379	0.00126	CcSEcCtD
Bimatoprost—Pain—Vinorelbine—lung cancer	0.000378	0.00126	CcSEcCtD
Bimatoprost—Mediastinal disorder—Paclitaxel—lung cancer	0.000377	0.00126	CcSEcCtD
Bimatoprost—Hypertension—Gemcitabine—lung cancer	0.000375	0.00125	CcSEcCtD
Bimatoprost—Asthenia—Topotecan—lung cancer	0.000371	0.00124	CcSEcCtD
Bimatoprost—Chest pain—Gemcitabine—lung cancer	0.00037	0.00123	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000368	0.00123	CcSEcCtD
Bimatoprost—Asthenia—Erlotinib—lung cancer	0.000367	0.00122	CcSEcCtD
Bimatoprost—Pruritus—Topotecan—lung cancer	0.000365	0.00122	CcSEcCtD
Bimatoprost—Erythema—Paclitaxel—lung cancer	0.000364	0.00121	CcSEcCtD
Bimatoprost—Infection—Irinotecan—lung cancer	0.000362	0.00121	CcSEcCtD
Bimatoprost—Pruritus—Erlotinib—lung cancer	0.000361	0.00121	CcSEcCtD
Bimatoprost—Nervous system disorder—Irinotecan—lung cancer	0.000357	0.00119	CcSEcCtD
Bimatoprost—Tension—Paclitaxel—lung cancer	0.000357	0.00119	CcSEcCtD
Bimatoprost—Rhinitis—Docetaxel—lung cancer	0.000355	0.00118	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—lung cancer	0.000354	0.00118	CcSEcCtD
Bimatoprost—Nervousness—Paclitaxel—lung cancer	0.000354	0.00118	CcSEcCtD
Bimatoprost—Infection—Gemcitabine—lung cancer	0.000353	0.00118	CcSEcCtD
Bimatoprost—Pharyngitis—Docetaxel—lung cancer	0.000352	0.00117	CcSEcCtD
Bimatoprost—Dizziness—Vinblastine—lung cancer	0.000352	0.00117	CcSEcCtD
Bimatoprost—Oedema peripheral—Docetaxel—lung cancer	0.000349	0.00116	CcSEcCtD
Bimatoprost—Connective tissue disorder—Docetaxel—lung cancer	0.000348	0.00116	CcSEcCtD
Bimatoprost—Nervous system disorder—Gemcitabine—lung cancer	0.000348	0.00116	CcSEcCtD
Bimatoprost—Skin disorder—Gemcitabine—lung cancer	0.000345	0.00115	CcSEcCtD
Bimatoprost—Anxiety—Cisplatin—lung cancer	0.000344	0.00115	CcSEcCtD
Bimatoprost—Vision blurred—Paclitaxel—lung cancer	0.000343	0.00114	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000343	0.00114	CcSEcCtD
Bimatoprost—Visual impairment—Docetaxel—lung cancer	0.000342	0.00114	CcSEcCtD
Bimatoprost—Dizziness—Topotecan—lung cancer	0.000341	0.00114	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—lung cancer	0.000341	0.00114	CcSEcCtD
Bimatoprost—Dizziness—Erlotinib—lung cancer	0.000338	0.00113	CcSEcCtD
Bimatoprost—Vertigo—Etoposide—lung cancer	0.000334	0.00111	CcSEcCtD
Bimatoprost—Headache—Vinblastine—lung cancer	0.000333	0.00111	CcSEcCtD
Bimatoprost—Eye disorder—Docetaxel—lung cancer	0.000331	0.0011	CcSEcCtD
Bimatoprost—Insomnia—Irinotecan—lung cancer	0.00033	0.0011	CcSEcCtD
Bimatoprost—Infection—Cisplatin—lung cancer	0.000329	0.0011	CcSEcCtD
Bimatoprost—Vertigo—Paclitaxel—lung cancer	0.000327	0.00109	CcSEcCtD
Bimatoprost—Rash—Topotecan—lung cancer	0.000326	0.00109	CcSEcCtD
Bimatoprost—Dermatitis—Topotecan—lung cancer	0.000325	0.00108	CcSEcCtD
Bimatoprost—Dyspnoea—Irinotecan—lung cancer	0.000325	0.00108	CcSEcCtD
Bimatoprost—Nervous system disorder—Cisplatin—lung cancer	0.000324	0.00108	CcSEcCtD
Bimatoprost—Cough—Etoposide—lung cancer	0.000324	0.00108	CcSEcCtD
Bimatoprost—Somnolence—Irinotecan—lung cancer	0.000324	0.00108	CcSEcCtD
Bimatoprost—Headache—Topotecan—lung cancer	0.000324	0.00108	CcSEcCtD
Bimatoprost—Rash—Erlotinib—lung cancer	0.000322	0.00107	CcSEcCtD
Bimatoprost—Dermatitis—Erlotinib—lung cancer	0.000322	0.00107	CcSEcCtD
Bimatoprost—Palpitations—Paclitaxel—lung cancer	0.000322	0.00107	CcSEcCtD
Bimatoprost—Angiopathy—Docetaxel—lung cancer	0.000322	0.00107	CcSEcCtD
Bimatoprost—Skin disorder—Cisplatin—lung cancer	0.000321	0.00107	CcSEcCtD
Bimatoprost—Insomnia—Gemcitabine—lung cancer	0.000321	0.00107	CcSEcCtD
Bimatoprost—Dyspepsia—Irinotecan—lung cancer	0.000321	0.00107	CcSEcCtD
Bimatoprost—Hypertension—Etoposide—lung cancer	0.000321	0.00107	CcSEcCtD
Bimatoprost—Headache—Erlotinib—lung cancer	0.00032	0.00107	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—lung cancer	0.00032	0.00107	CcSEcCtD
Bimatoprost—Mediastinal disorder—Docetaxel—lung cancer	0.000319	0.00107	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—lung cancer	0.000319	0.00106	CcSEcCtD
Bimatoprost—Cough—Paclitaxel—lung cancer	0.000318	0.00106	CcSEcCtD
Bimatoprost—Asthenia—Vinorelbine—lung cancer	0.000317	0.00106	CcSEcCtD
Bimatoprost—Dyspnoea—Gemcitabine—lung cancer	0.000316	0.00105	CcSEcCtD
Bimatoprost—Chest pain—Etoposide—lung cancer	0.000316	0.00105	CcSEcCtD
Bimatoprost—Nausea—Vinblastine—lung cancer	0.000316	0.00105	CcSEcCtD
Bimatoprost—Somnolence—Gemcitabine—lung cancer	0.000316	0.00105	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Irinotecan—lung cancer	0.000315	0.00105	CcSEcCtD
Bimatoprost—Hypertension—Paclitaxel—lung cancer	0.000314	0.00105	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000314	0.00105	CcSEcCtD
Bimatoprost—Pruritus—Vinorelbine—lung cancer	0.000313	0.00104	CcSEcCtD
Bimatoprost—Pain—Irinotecan—lung cancer	0.000312	0.00104	CcSEcCtD
Bimatoprost—Chest pain—Paclitaxel—lung cancer	0.00031	0.00103	CcSEcCtD
Bimatoprost—Anxiety—Paclitaxel—lung cancer	0.000309	0.00103	CcSEcCtD
Bimatoprost—Erythema—Docetaxel—lung cancer	0.000309	0.00103	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000308	0.00103	CcSEcCtD
Bimatoprost—Nausea—Topotecan—lung cancer	0.000307	0.00102	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000306	0.00102	CcSEcCtD
Bimatoprost—Pain—Gemcitabine—lung cancer	0.000303	0.00101	CcSEcCtD
Bimatoprost—Nausea—Erlotinib—lung cancer	0.000303	0.00101	CcSEcCtD
Bimatoprost—Dry mouth—Paclitaxel—lung cancer	0.000303	0.00101	CcSEcCtD
Bimatoprost—Infection—Etoposide—lung cancer	0.000301	0.001	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—lung cancer	0.000297	0.000989	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—lung cancer	0.000295	0.000984	CcSEcCtD
Bimatoprost—Infection—Paclitaxel—lung cancer	0.000295	0.000984	CcSEcCtD
Bimatoprost—Dyspnoea—Cisplatin—lung cancer	0.000295	0.000983	CcSEcCtD
Bimatoprost—Skin disorder—Etoposide—lung cancer	0.000294	0.000981	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—lung cancer	0.000293	0.000977	CcSEcCtD
Bimatoprost—Dizziness—Vinorelbine—lung cancer	0.000292	0.000974	CcSEcCtD
Bimatoprost—Nervous system disorder—Paclitaxel—lung cancer	0.000291	0.000971	CcSEcCtD
Bimatoprost—Skin disorder—Paclitaxel—lung cancer	0.000289	0.000962	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—lung cancer	0.000286	0.000953	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Cisplatin—lung cancer	0.000286	0.000952	CcSEcCtD
Bimatoprost—Depression—Methotrexate—lung cancer	0.000284	0.000946	CcSEcCtD
Bimatoprost—Pain—Cisplatin—lung cancer	0.000283	0.000943	CcSEcCtD
Bimatoprost—Rash—Vinorelbine—lung cancer	0.000279	0.000929	CcSEcCtD
Bimatoprost—Dermatitis—Vinorelbine—lung cancer	0.000278	0.000928	CcSEcCtD
Bimatoprost—Headache—Vinorelbine—lung cancer	0.000277	0.000923	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—lung cancer	0.000276	0.000921	CcSEcCtD
Bimatoprost—Palpitations—Docetaxel—lung cancer	0.000273	0.000909	CcSEcCtD
Bimatoprost—Dyspnoea—Etoposide—lung cancer	0.00027	0.000901	CcSEcCtD
Bimatoprost—Somnolence—Etoposide—lung cancer	0.000269	0.000898	CcSEcCtD
Bimatoprost—Cough—Docetaxel—lung cancer	0.000269	0.000898	CcSEcCtD
Bimatoprost—Insomnia—Paclitaxel—lung cancer	0.000269	0.000896	CcSEcCtD
Bimatoprost—Hypertension—Docetaxel—lung cancer	0.000266	0.000888	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—lung cancer	0.000266	0.000886	CcSEcCtD
Bimatoprost—Dyspnoea—Paclitaxel—lung cancer	0.000265	0.000883	CcSEcCtD
Bimatoprost—Somnolence—Paclitaxel—lung cancer	0.000264	0.000881	CcSEcCtD
Bimatoprost—Chest pain—Docetaxel—lung cancer	0.000263	0.000876	CcSEcCtD
Bimatoprost—Nausea—Vinorelbine—lung cancer	0.000262	0.000875	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—lung cancer	0.000262	0.000872	CcSEcCtD
Bimatoprost—Dyspepsia—Paclitaxel—lung cancer	0.000262	0.000872	CcSEcCtD
Bimatoprost—Asthenia—Irinotecan—lung cancer	0.000261	0.000871	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000261	0.00087	CcSEcCtD
Bimatoprost—Pain—Etoposide—lung cancer	0.000259	0.000864	CcSEcCtD
Bimatoprost—Dry mouth—Docetaxel—lung cancer	0.000257	0.000857	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000257	0.000856	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000257	0.000855	CcSEcCtD
Bimatoprost—Asthenia—Gemcitabine—lung cancer	0.000255	0.000849	CcSEcCtD
Bimatoprost—Pain—Paclitaxel—lung cancer	0.000254	0.000847	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—lung cancer	0.000254	0.000845	CcSEcCtD
Bimatoprost—Pruritus—Gemcitabine—lung cancer	0.000251	0.000837	CcSEcCtD
Bimatoprost—Infection—Docetaxel—lung cancer	0.00025	0.000834	CcSEcCtD
Bimatoprost—Nervous system disorder—Docetaxel—lung cancer	0.000247	0.000823	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—lung cancer	0.000246	0.000821	CcSEcCtD
Bimatoprost—Skin disorder—Docetaxel—lung cancer	0.000245	0.000816	CcSEcCtD
Bimatoprost—Dizziness—Irinotecan—lung cancer	0.000241	0.000803	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—lung cancer	0.000239	0.000796	CcSEcCtD
Bimatoprost—Asthenia—Cisplatin—lung cancer	0.000237	0.000791	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—lung cancer	0.000232	0.000773	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—lung cancer	0.000231	0.000771	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—lung cancer	0.00023	0.000768	CcSEcCtD
Bimatoprost—Rash—Irinotecan—lung cancer	0.00023	0.000766	CcSEcCtD
Bimatoprost—Dermatitis—Irinotecan—lung cancer	0.00023	0.000765	CcSEcCtD
Bimatoprost—Headache—Irinotecan—lung cancer	0.000228	0.000761	CcSEcCtD
Bimatoprost—Insomnia—Docetaxel—lung cancer	0.000228	0.000759	CcSEcCtD
Bimatoprost—Dyspnoea—Docetaxel—lung cancer	0.000225	0.000749	CcSEcCtD
Bimatoprost—Somnolence—Docetaxel—lung cancer	0.000224	0.000746	CcSEcCtD
Bimatoprost—Rash—Gemcitabine—lung cancer	0.000224	0.000746	CcSEcCtD
Bimatoprost—Dermatitis—Gemcitabine—lung cancer	0.000224	0.000745	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—lung cancer	0.000222	0.000741	CcSEcCtD
Bimatoprost—Headache—Gemcitabine—lung cancer	0.000222	0.000741	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—lung cancer	0.000222	0.000739	CcSEcCtD
Bimatoprost—Dyspepsia—Docetaxel—lung cancer	0.000222	0.000739	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—lung cancer	0.00022	0.000732	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—lung cancer	0.000218	0.000727	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Docetaxel—lung cancer	0.000217	0.000725	CcSEcCtD
Bimatoprost—Asthenia—Etoposide—lung cancer	0.000217	0.000725	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—lung cancer	0.000217	0.000725	CcSEcCtD
Bimatoprost—Nausea—Irinotecan—lung cancer	0.000216	0.000721	CcSEcCtD
Bimatoprost—Pain—Docetaxel—lung cancer	0.000215	0.000718	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—lung cancer	0.000214	0.000715	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—lung cancer	0.000213	0.000711	CcSEcCtD
Bimatoprost—Asthenia—Paclitaxel—lung cancer	0.000213	0.000711	CcSEcCtD
Bimatoprost—Nausea—Gemcitabine—lung cancer	0.000211	0.000703	CcSEcCtD
Bimatoprost—Pruritus—Paclitaxel—lung cancer	0.00021	0.000701	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—lung cancer	0.00021	0.000699	CcSEcCtD
Bimatoprost—Rash—Cisplatin—lung cancer	0.000209	0.000695	CcSEcCtD
Bimatoprost—Dermatitis—Cisplatin—lung cancer	0.000208	0.000695	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—lung cancer	0.000207	0.000689	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—lung cancer	0.000201	0.000669	CcSEcCtD
Bimatoprost—Dizziness—Etoposide—lung cancer	0.0002	0.000668	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—lung cancer	0.0002	0.000666	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—lung cancer	0.000199	0.000665	CcSEcCtD
Bimatoprost—Dizziness—Paclitaxel—lung cancer	0.000196	0.000655	CcSEcCtD
Bimatoprost—Nausea—Cisplatin—lung cancer	0.000196	0.000655	CcSEcCtD
Bimatoprost—Cough—Methotrexate—lung cancer	0.000194	0.000647	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—lung cancer	0.000193	0.000642	CcSEcCtD
Bimatoprost—Rash—Etoposide—lung cancer	0.000191	0.000637	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—lung cancer	0.000191	0.000636	CcSEcCtD
Bimatoprost—Headache—Etoposide—lung cancer	0.00019	0.000633	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—lung cancer	0.000189	0.000631	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—lung cancer	0.000189	0.00063	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000188	0.000627	CcSEcCtD
Bimatoprost—Rash—Paclitaxel—lung cancer	0.000187	0.000625	CcSEcCtD
Bimatoprost—Dermatitis—Paclitaxel—lung cancer	0.000187	0.000624	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—lung cancer	0.000187	0.000624	CcSEcCtD
Bimatoprost—Headache—Paclitaxel—lung cancer	0.000186	0.000621	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—lung cancer	0.000182	0.000605	CcSEcCtD
Bimatoprost—Asthenia—Docetaxel—lung cancer	0.000181	0.000602	CcSEcCtD
Bimatoprost—Infection—Methotrexate—lung cancer	0.00018	0.000601	CcSEcCtD
Bimatoprost—Nausea—Etoposide—lung cancer	0.00018	0.0006	CcSEcCtD
Bimatoprost—Pruritus—Docetaxel—lung cancer	0.000178	0.000594	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—lung cancer	0.000178	0.000593	CcSEcCtD
Bimatoprost—Nausea—Paclitaxel—lung cancer	0.000176	0.000588	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—lung cancer	0.000176	0.000588	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—lung cancer	0.000173	0.000577	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—lung cancer	0.00017	0.000567	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—lung cancer	0.000168	0.00056	CcSEcCtD
Bimatoprost—Dizziness—Docetaxel—lung cancer	0.000167	0.000555	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—lung cancer	0.000166	0.000554	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—lung cancer	0.000164	0.000547	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—lung cancer	0.000164	0.000547	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—lung cancer	0.000163	0.000545	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000163	0.000543	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—lung cancer	0.000162	0.00054	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—lung cancer	0.000161	0.000538	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—lung cancer	0.00016	0.000535	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—lung cancer	0.00016	0.000533	CcSEcCtD
Bimatoprost—Rash—Docetaxel—lung cancer	0.000159	0.000529	CcSEcCtD
Bimatoprost—Dermatitis—Docetaxel—lung cancer	0.000159	0.000529	CcSEcCtD
Bimatoprost—Headache—Docetaxel—lung cancer	0.000158	0.000526	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—lung cancer	0.000157	0.000522	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—lung cancer	0.000156	0.000521	CcSEcCtD
Bimatoprost—Pain—Methotrexate—lung cancer	0.000155	0.000517	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—lung cancer	0.000154	0.000514	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—lung cancer	0.000153	0.000509	CcSEcCtD
Bimatoprost—Nausea—Docetaxel—lung cancer	0.00015	0.000499	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—lung cancer	0.000142	0.000474	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—lung cancer	0.00014	0.000467	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—lung cancer	0.00014	0.000466	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—lung cancer	0.000138	0.000461	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000136	0.000452	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—lung cancer	0.000134	0.000448	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—lung cancer	0.00013	0.000434	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—lung cancer	0.000128	0.000428	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—lung cancer	0.00012	0.0004	CcSEcCtD
Bimatoprost—Rash—Methotrexate—lung cancer	0.000114	0.000382	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—lung cancer	0.000114	0.000381	CcSEcCtD
Bimatoprost—Headache—Methotrexate—lung cancer	0.000114	0.000379	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—lung cancer	0.000113	0.000376	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—lung cancer	0.000111	0.000371	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—lung cancer	0.000108	0.000359	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—lung cancer	0.000104	0.000347	CcSEcCtD
Bimatoprost—Rash—Doxorubicin—lung cancer	9.91e-05	0.00033	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—lung cancer	9.9e-05	0.00033	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—lung cancer	9.85e-05	0.000328	CcSEcCtD
Bimatoprost—Nausea—Doxorubicin—lung cancer	9.34e-05	0.000311	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—lung cancer	6.3e-05	0.000316	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KIT—lung cancer	6.27e-05	0.000315	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—lung cancer	6.27e-05	0.000315	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APC—lung cancer	6.27e-05	0.000315	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—NRAS—lung cancer	6.27e-05	0.000315	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGF—lung cancer	6.25e-05	0.000314	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RAF1—lung cancer	6.23e-05	0.000313	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HES1—lung cancer	6.21e-05	0.000312	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGF—lung cancer	6.2e-05	0.000311	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—lung cancer	6.15e-05	0.000309	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1R—lung cancer	6.1e-05	0.000307	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RAF1—lung cancer	6.09e-05	0.000306	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CB—lung cancer	6.08e-05	0.000305	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—lung cancer	6.02e-05	0.000302	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—MAPK3—lung cancer	6e-05	0.000302	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HES1—lung cancer	5.99e-05	0.000301	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—lung cancer	5.97e-05	0.0003	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CB—lung cancer	5.95e-05	0.000299	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BRAF—lung cancer	5.94e-05	0.000299	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BRAF—lung cancer	5.89e-05	0.000296	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6R—lung cancer	5.87e-05	0.000295	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CREBBP—lung cancer	5.86e-05	0.000294	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—lung cancer	5.84e-05	0.000294	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6R—lung cancer	5.82e-05	0.000292	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CREBBP—lung cancer	5.81e-05	0.000292	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB3—lung cancer	5.8e-05	0.000292	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOA1—lung cancer	5.8e-05	0.000291	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—lung cancer	5.72e-05	0.000287	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—lung cancer	5.71e-05	0.000287	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB3—lung cancer	5.68e-05	0.000285	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAP2K1—lung cancer	5.59e-05	0.000281	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—lung cancer	5.58e-05	0.000281	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—lung cancer	5.56e-05	0.000279	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—lung cancer	5.56e-05	0.000279	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.55e-05	0.000279	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAP2K1—lung cancer	5.55e-05	0.000279	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—lung cancer	5.51e-05	0.000277	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB3—lung cancer	5.48e-05	0.000275	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—lung cancer	5.46e-05	0.000275	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—lung cancer	5.46e-05	0.000274	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—lung cancer	5.44e-05	0.000274	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGFR1—lung cancer	5.4e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—lung cancer	5.39e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—lung cancer	5.32e-05	0.000267	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—lung cancer	5.29e-05	0.000266	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR1—lung cancer	5.29e-05	0.000266	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—lung cancer	5.25e-05	0.000264	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—lung cancer	5.21e-05	0.000262	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOA1—lung cancer	5.13e-05	0.000258	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR1—lung cancer	5.1e-05	0.000256	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—lung cancer	5.09e-05	0.000256	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—lung cancer	5.04e-05	0.000253	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOA1—lung cancer	5.02e-05	0.000252	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—lung cancer	5.02e-05	0.000252	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—lung cancer	4.98e-05	0.00025	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MDM2—lung cancer	4.98e-05	0.00025	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAF1—lung cancer	4.96e-05	0.000249	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—lung cancer	4.96e-05	0.000249	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MDM2—lung cancer	4.94e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAF1—lung cancer	4.92e-05	0.000247	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CREBBP—lung cancer	4.91e-05	0.000247	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—lung cancer	4.91e-05	0.000247	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—lung cancer	4.87e-05	0.000245	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOA1—lung cancer	4.85e-05	0.000244	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTOR—lung cancer	4.84e-05	0.000243	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—lung cancer	4.84e-05	0.000243	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—lung cancer	4.83e-05	0.000243	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—lung cancer	4.8e-05	0.000241	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—lung cancer	4.8e-05	0.000241	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTOR—lung cancer	4.8e-05	0.000241	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—lung cancer	4.8e-05	0.000241	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—lung cancer	4.69e-05	0.000235	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KIT—lung cancer	4.69e-05	0.000235	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—lung cancer	4.69e-05	0.000235	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—NRAS—lung cancer	4.69e-05	0.000235	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—lung cancer	4.65e-05	0.000234	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGF—lung cancer	4.63e-05	0.000233	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—lung cancer	4.62e-05	0.000232	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—lung cancer	4.59e-05	0.000231	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KIT—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—NRAS—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRAS—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGF—lung cancer	4.53e-05	0.000228	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK3—lung cancer	4.49e-05	0.000226	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—lung cancer	4.46e-05	0.000224	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—lung cancer	4.46e-05	0.000224	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—lung cancer	4.43e-05	0.000222	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—lung cancer	4.43e-05	0.000222	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KIT—lung cancer	4.43e-05	0.000222	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—lung cancer	4.42e-05	0.000222	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—lung cancer	4.41e-05	0.000222	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BRAF—lung cancer	4.41e-05	0.000221	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK3—lung cancer	4.39e-05	0.000221	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—lung cancer	4.39e-05	0.000221	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGF—lung cancer	4.37e-05	0.00022	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—lung cancer	4.37e-05	0.000219	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6R—lung cancer	4.35e-05	0.000219	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CREBBP—lung cancer	4.35e-05	0.000218	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BRAF—lung cancer	4.31e-05	0.000217	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—lung cancer	4.3e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JUN—lung cancer	4.29e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—lung cancer	4.27e-05	0.000215	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6R—lung cancer	4.26e-05	0.000214	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CREBBP—lung cancer	4.25e-05	0.000214	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—lung cancer	4.21e-05	0.000212	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1A—lung cancer	4.19e-05	0.000211	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—lung cancer	4.18e-05	0.00021	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—lung cancer	4.18e-05	0.00021	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—lung cancer	4.17e-05	0.00021	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BRAF—lung cancer	4.16e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1A—lung cancer	4.16e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—lung cancer	4.15e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAP2K1—lung cancer	4.15e-05	0.000208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6R—lung cancer	4.11e-05	0.000206	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CREBBP—lung cancer	4.1e-05	0.000206	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—lung cancer	4.08e-05	0.000205	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAP2K1—lung cancer	4.06e-05	0.000204	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—lung cancer	4.06e-05	0.000204	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—lung cancer	4.05e-05	0.000203	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—lung cancer	4.03e-05	0.000203	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—lung cancer	4.03e-05	0.000203	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—lung cancer	4.02e-05	0.000202	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—lung cancer	3.99e-05	0.000201	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EP300—lung cancer	3.99e-05	0.000201	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EP300—lung cancer	3.96e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—lung cancer	3.95e-05	0.000198	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAP2K1—lung cancer	3.92e-05	0.000197	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—lung cancer	3.89e-05	0.000195	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—lung cancer	3.88e-05	0.000195	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—lung cancer	3.85e-05	0.000193	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—lung cancer	3.75e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—lung cancer	3.74e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NRAS—lung cancer	3.73e-05	0.000188	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—lung cancer	3.71e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—lung cancer	3.71e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NRAS—lung cancer	3.7e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MDM2—lung cancer	3.69e-05	0.000185	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAF1—lung cancer	3.68e-05	0.000185	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—lung cancer	3.64e-05	0.000183	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—lung cancer	3.63e-05	0.000182	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MDM2—lung cancer	3.61e-05	0.000182	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAF1—lung cancer	3.6e-05	0.000181	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—lung cancer	3.59e-05	0.00018	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTOR—lung cancer	3.59e-05	0.00018	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK3—lung cancer	3.58e-05	0.00018	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—lung cancer	3.56e-05	0.000179	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK3—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTOR—lung cancer	3.52e-05	0.000177	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—lung cancer	3.52e-05	0.000177	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—lung cancer	3.5e-05	0.000176	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MDM2—lung cancer	3.49e-05	0.000175	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—lung cancer	3.48e-05	0.000175	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAF1—lung cancer	3.47e-05	0.000175	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—lung cancer	3.45e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—lung cancer	3.45e-05	0.000173	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—lung cancer	3.44e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRAS—lung cancer	3.43e-05	0.000172	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—lung cancer	3.4e-05	0.000171	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTOR—lung cancer	3.39e-05	0.00017	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—lung cancer	3.39e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—lung cancer	3.38e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—lung cancer	3.37e-05	0.000169	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRAS—lung cancer	3.36e-05	0.000169	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—EP300—lung cancer	3.34e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—lung cancer	3.33e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—lung cancer	3.3e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—lung cancer	3.3e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—lung cancer	3.28e-05	0.000165	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—lung cancer	3.26e-05	0.000164	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—lung cancer	3.26e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—lung cancer	3.23e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—lung cancer	3.23e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—lung cancer	3.22e-05	0.000162	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—lung cancer	3.21e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—lung cancer	3.21e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JUN—lung cancer	3.21e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—lung cancer	3.19e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—lung cancer	3.15e-05	0.000158	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JUN—lung cancer	3.14e-05	0.000158	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—lung cancer	3.12e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—lung cancer	3.12e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—lung cancer	3.11e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1A—lung cancer	3.11e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—lung cancer	3.1e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—lung cancer	3.06e-05	0.000154	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1A—lung cancer	3.04e-05	0.000153	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—lung cancer	3.04e-05	0.000153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—lung cancer	3.04e-05	0.000153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JUN—lung cancer	3.03e-05	0.000152	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—lung cancer	3.03e-05	0.000152	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—lung cancer	2.96e-05	0.000149	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EP300—lung cancer	2.96e-05	0.000149	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—lung cancer	2.95e-05	0.000148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—lung cancer	2.95e-05	0.000148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1A—lung cancer	2.94e-05	0.000148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—lung cancer	2.93e-05	0.000147	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—lung cancer	2.93e-05	0.000147	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EP300—lung cancer	2.9e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—lung cancer	2.88e-05	0.000145	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—lung cancer	2.83e-05	0.000142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—lung cancer	2.82e-05	0.000142	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—lung cancer	2.8e-05	0.000141	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EP300—lung cancer	2.79e-05	0.00014	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—lung cancer	2.78e-05	0.000139	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NRAS—lung cancer	2.77e-05	0.000139	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—lung cancer	2.74e-05	0.000138	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HRAS—lung cancer	2.73e-05	0.000137	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—lung cancer	2.72e-05	0.000137	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—lung cancer	2.72e-05	0.000136	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NRAS—lung cancer	2.71e-05	0.000136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRAS—lung cancer	2.71e-05	0.000136	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK3—lung cancer	2.65e-05	0.000133	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—lung cancer	2.65e-05	0.000133	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—lung cancer	2.62e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NRAS—lung cancer	2.61e-05	0.000131	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—lung cancer	2.61e-05	0.000131	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK3—lung cancer	2.6e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—lung cancer	2.59e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—lung cancer	2.58e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—lung cancer	2.52e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—lung cancer	2.52e-05	0.000127	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK3—lung cancer	2.5e-05	0.000126	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—lung cancer	2.47e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—lung cancer	2.47e-05	0.000124	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—lung cancer	2.44e-05	0.000122	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—lung cancer	2.41e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—lung cancer	2.39e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—lung cancer	2.38e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—lung cancer	2.38e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—lung cancer	2.33e-05	0.000117	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—lung cancer	2.25e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—lung cancer	2.19e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—lung cancer	2.14e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—lung cancer	2.12e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—lung cancer	2.07e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—lung cancer	2.07e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRAS—lung cancer	2.03e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—lung cancer	2.02e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—lung cancer	2e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRAS—lung cancer	1.98e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—lung cancer	1.94e-05	9.74e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRAS—lung cancer	1.91e-05	9.61e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—lung cancer	1.9e-05	9.53e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—lung cancer	1.83e-05	9.2e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—lung cancer	1.79e-05	8.99e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—lung cancer	1.75e-05	8.8e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—lung cancer	1.69e-05	8.49e-05	CbGpPWpGaD
